Enhanced Systems and Methods for Treating Prostate Cancer with Heated Condensable Vapor

Improved systems and methods for treating prostate cancer using heated condensable vapor, providing enhanced efficacy, safety, and efficiency

The original patent's limitations included the risk of ablating tissue outside the prostate and the need for improved targeting and control. The new inventive concept addresses these limitations by introducing thermally-insulated shafts, multi-lumen shafts, and advanced vapor generators, enabling more precise and effective treatment

The new systems and methods comprise vapor delivery devices with thermally-insulated shafts and advanced vapor generators, capable of generating heated condensable vapor at temperatures above 100°C. The devices are designed for trans-perineal or trans-urethral access, ensuring targeted treatment of prostate tissue while minimizing damage to surrounding tissues. The vapor delivery needles feature hollow shafts with diameters less than 1 mm and lengths of at least 10 cm, allowing for precise navigation and treatment. The vapor generators are configured to deliver vapor at pressures above 10 psi and flow rates above 10 ml/min, ensuring efficient ablation of prostate tissue while minimizing bleeding and pain

The new inventive concept introduces novel features, such as thermally-insulated shafts, multi-lumen shafts, and advanced vapor generators, which provide improved targeting, control, and efficacy in treating prostate cancer. These advancements are non-obvious and provide a significant improvement over the original patent

Alternative embodiments may include vapor delivery devices with adjustable vapor flow rates, temperature-controlled vapor generators, or integrated imaging systems for real-time monitoring. Variations may also include different shaft materials, vapor generator designs, or treatment protocols tailored to specific patient needs

The enhanced systems and methods for treating prostate cancer with heated condensable vapor have significant commercial potential in the medical device industry, particularly in the fields of urology and oncology. The target market includes hospitals, clinics, and medical centers specializing in prostate cancer treatment, with potential for widespread adoption and revenue growth